C Reactive Protein (CRP)
C Reactive Protein (CRP)
Selecione o idioma
Powered by Tradutor (https://translate.google.com)
Article Author:
Sara Nehring
Article Author:
Amandeep Goyal
Article Author:
Pankaj Bansal
Article Editor:
Bhupendra Patel
Updated:
6/5/2020 9:08:53 PM
PubMed Link:
C Reactive Protein (CRP) (https://www.ncbi.nlm.nih.gov/books/n/statpearls/article-
18744)
Introduction
C-reactive protein (CRP) was discovered by Tillett and Francis in 1930. The name CRP
arose because it was rst identi ed as a substance in the serum of patients with
acute in ammation that reacted with the "c" carbohydrate antibody of the capsule of
pneumococcus.
CRP is a pentameric protein synthesized by the liver, whose level rises in response
to in ammation. CRP is an acute-phase reactant protein that is primarily induced by
the IL-6 action on the gene responsible for transcription of CRP during the acute
phase of an in ammatory/infectious process. There is some question of whether
dysregulation of the role of CRP in the clearance of apoptotic cells and cellular debris
plays a role in the pathogenesis of systemic lupus erythematosus (SLE), but this has
not been de nitively demonstrated. It has been demonstrated to have
some protective properties in animal studies on lung tissue in alveolitis by reducing
neutrophil-mediated damage to the alveoli and protein leakage into the lung.
CRP has both proin ammatory and anti-in ammatory properties. It plays a role in
the recognition and clearance of foreign pathogens and damaged cells by binding to
the phosphocholine, phospholipids, histone, chromatin, and bronectin. It can
activate the classic complement pathway and also activates phagocytic cells via Fc
receptors to expedite the removal of cellular debris and damaged or apoptotic cells
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 1/6
10/08/2020 C Reactive Protein (CRP) Article - StatPearls
and foreign pathogens. This can become pathologic, however, when it is activated by
autoantibodies displaying the phosphocholine arm in auto-immune processes, such
as idiopathic thrombocytopenic purpura (ITP). It can also worsen tissue damage in
certain cases by activation of the complement system and thus in ammatory
cytokines.[1][2][3]
There are numerous causes of an elevated C-reactive protein. These include acute
and chronic conditions, and these can be infectious or non-infectious in etiology.
However, markedly elevated levels of CRP are most often associated with an
infectious cause[4] (an example of pathogen-associated molecular pattern
recognition). Trauma can also cause elevations in CRP (alarmin response). More
modest elevations tend to be associated with a broader spectrum of etiologies,
ranging from sleep disturbances to periodontal disease.
Specimen Collection
A blood specimen is taken from a peripheral venous draw. A phlebotomist performs
the procedure in most cases. The phlebotomist secures a snug, rubber band around
the upper arm, and the patient pumps his or her st several times.
The phlebotomist palpates the vein to con rm the location and cleanses the area
with an alcohol prep pad. Once the area air dries, the practitioner introduces a
needle into the vein and draws a vial of blood. He or she removes the band from the
patient's arm, and then removes the needle and applies pressure to the
venipuncture site until hemostasis occurs, usually within one minute. A bandage is
applied over the site.
The patient's medications should be reviewed, as these can a ect the outcome of the
test. Fasting is not required before the blood draw. There are no special procedures
required. Complications include oozing at the draw site, bruising or mild tenderness
at the site, or very rarely, infection at the venipuncture site. Other bodily uids, such
as synovial uid, can be tested for in this manner, but frequently are not.
Immunoassays and laser nephelometry are the methods to quantify CRP levels and
are cheap, accurate and fast. To detect lower levels of CRP (0.3 to 1.0 mg/dL), high-
sensitivity CRP methods are recommended as the usual CRP detection tests are less
precise. High-sensitivity CRP only denotes the assay process used, allowing for
detection of lower levels of CRP, and not a di erent, or more speci c, di erential
diagnosis.
Indications
This test is performed when the physician suspects acute or chronic in ammation
(e.g, SLE or rheumatoid arthritis (RA)) or infection. The utility of the hs-CRP for cardiac
screening is debatable. There is some correlation between cardiovascular risk and
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 2/6
10/08/2020 C Reactive Protein (CRP) Article - StatPearls
elevated hs-CRP, but the application of this is still controversial especially given the
poor speci city of this test, and it is currently undergoing more evaluation.[5][6][7]
Less than 0.3 mg/dL: Normal (level seen in most healthy adults).
0.3 to 1.0 mg/dL: Normal or minor elevation (can be seen in obesity, pregnancy,
depression, diabetes, common cold, gingivitis, periodontitis, sedentary lifestyle,
cigarette smoking, and genetic polymorphisms).
1.0 to 10.0 mg/dL: Moderate elevation (Systemic in ammation such as RA, SLE or
other autoimmune diseases, malignancies, myocardial infarction, pancreatitis,
bronchitis).
More than 10.0 mg/dL: Marked elevation (Acute bacterial infections, viral infections,
systemic vasculitis, major trauma).
Interfering Factors
Certain medications, such as non-steroidal anti-in ammatory drugs (NSAIDs) will
falsely decrease CRP levels. Statins, as well, have been known to reduce CRP levels
falsely. Recent injury or illness can falsely elevate levels, particularly when using this
test for cardiac risk strati cation. Magnesium supplementation also can decrease
CRP levels.
As mentioned above, mild elevations in CRP can be seen without any systemic or
in ammatory disease. Females and elderly patients have higher levels of CRP.
Obesity, insomnia, depression, smoking, and diabetes can all contribute to mild
elevations in CRP, and the results shall be interpreted with caution in individuals with
these comorbidities.
Complications
Given the highly variable causality of elevated CRP, marginal elevations in the CRP
can be di cult to interpret and should not be used as an isolated test result
interpreted as appropriate for the clinical picture. It is useful in suggesting infection
versus in ammation if the levels are extremely high, but levels between 1 mg/dL and
10 mg/dL can be di cult to interpret accurately. Chronic conditions, such as
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 3/6
10/08/2020 C Reactive Protein (CRP) Article - StatPearls
in ammatory arthritis or SLE, can make these levels elevated chronically, making it
harder to determine if there is any signi cance to an elevated hs-CRP level when
using it as a predictive marker for cardiovascular disease.
We recommend
Powered by
References
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 4/6
10/08/2020 C Reactive Protein (CRP) Article - StatPearls
[1] Cleland DA,Eranki AP, Procalcitonin 2019 Jan; [PubMed PMID: 30969616]
(http://www.ncbi.nlm.nih.gov/pubmed/30969616)
[2] Jungen MJ,Ter Meulen BC,van Osch T,Weinstein HC,Ostelo RWJG, In ammatory biomarkers in patients
with sciatica: a systematic review. BMC musculoskeletal disorders. 2019 Apr 9; [PubMed PMID:
30967132] (http://www.ncbi.nlm.nih.gov/pubmed/30967132)
[3] Kramer NE,Cosgrove VE,Dunlop K,Subramaniapillai M,McIntyre RS,Suppes T, A clinical model for
identifying an in ammatory phenotype in mood disorders. Journal of psychiatric research. 2019 Feb
10; [PubMed PMID: 30954775] (http://www.ncbi.nlm.nih.gov/pubmed/30954775)
[5] Eschborn S,Weitkamp JH, Procalcitonin versus C-reactive protein: review of kinetics and performance
for diagnosis of neonatal sepsis. Journal of perinatology : o cial journal of the California Perinatal
Association. 2019 Mar 29; [PubMed PMID: 30926891]
(http://www.ncbi.nlm.nih.gov/pubmed/30926891)
[6] Darooghegi Mofrad M,Milajerdi A,Koohdani F,Surkan PJ,Azadbakht L, Garlic Supplementation Reduces
Circulating C-reactive Protein, Tumor Necrosis Factor, and Interleukin-6 in Adults: A Systematic Review
and Meta-analysis of Randomized Controlled Trials. The Journal of nutrition. 2019 Apr 5; [PubMed
PMID: 30949665] (http://www.ncbi.nlm.nih.gov/pubmed/30949665)
[7] Dick AG,Magill N,White TCH,Kokkinakis M,Norman-Taylor F, C-reactive protein: what to expect after
bony hip surgery for nonambulatory children and adolescents with cerebral palsy. Journal of pediatric
orthopedics. Part B. 2019 Apr 3; [PubMed PMID: 30925527]
(http://www.ncbi.nlm.nih.gov/pubmed/30925527)
[8] Lee Y,McKechnie T,Doumouras AG,Handler C,Eskicioglu C,Gmora S,Anvari M,Hong D, Diagnostic Value
of C-Reactive Protein Levels in Postoperative Infectious Complications After Bariatric Surgery: a
Systematic Review and Meta-Analysis. Obesity surgery. 2019 Mar 21; [PubMed PMID: 30895509]
(http://www.ncbi.nlm.nih.gov/pubmed/30895509)
[9] Johns I,Moschonas KE,Medina J,Ossei-Gerning N,Kassianos G,Halcox JP, Risk classi cation in primary
prevention of CVD according to QRISK2 and JBS3 'heart age', and prevalence of elevated high-
sensitivity C reactive protein in the UK cohort of the EURIKA study. Open heart. 2018; [PubMed
PMID: 30564373] (http://www.ncbi.nlm.nih.gov/pubmed/30564373)
[10] Bhardwaj N,Ahmed MZ,Sharma S,Nayak A,Anvikar AR,Pande V, C-reactive protein as a prognostic
marker of {i}Plasmodiumfalciparum{/i} malaria severity. Journal of vector borne diseases. 2019 Apr-
Jun [PubMed PMID: 31397387] (http://www.ncbi.nlm.nih.gov/pubmed/31397387)
[11] Vuong NL,Le Duyen HT,Lam PK,Tam DTH,Vinh Chau NV,Van Kinh N,Chanpheaktra N,Lum LCS,Pleités
E,Jones NK,Simmons CP,Rosenberger K,Jaenisch T,Halleux C,Olliaro PL,Wills B,Yacoub S, C-reactive
protein as a potential biomarker for disease progression in dengue: a multi-country observational
study. BMC medicine. 2020 Feb 17 [PubMed PMID: 32063229]
(http://www.ncbi.nlm.nih.gov/pubmed/32063229)
[12] de Souza Pires-Neto O,da Silva Graça Amoras E,Queiroz MAF,Demachki S,da Silva Conde SR,Ishak
R,Cayres-Vallinoto IMV,Vallinoto ACR, Hepatic TLR4, MBL and CRP gene expression levels are
associated with chronic hepatitis C. Infection, genetics and evolution : journal of molecular
epidemiology and evolutionary genetics in infectious diseases. 2020 Jan 18 [PubMed PMID:
31962161] (http://www.ncbi.nlm.nih.gov/pubmed/31962161)
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 5/6
10/08/2020 C Reactive Protein (CRP) Article - StatPearls
© 2020 - StatPearls.com
Privacy Policy (/home/privacypolicy/)
Terms Of Use (/home/termsofuse/)
BUILD Version: 4.0.85.0
https://www.statpearls.com/kb/viewarticle/18744/?utm_source=TrendMD&utm_campaign=StatPearls_TrendMD_0&utm_medium=cpc 6/6